Literature DB >> 31859432

Factors associated with disability in patients with ulcerative colitis: A cross-sectional study.

Carla Marinelli1, Fabiana Zingone1, Marco Inferrera1, Greta Lorenzon1, Alessandra Rigo1, Sonia Facchin1, Roberta Caccaro1, Renata D'Incà1, Edoardo Vincenzo Savarino1.   

Abstract

OBJECTIVES: Ulcerative colitis (UC) can give rise to several restrictions of patients' working and social activities. We aimed to determine the association between disease chronicity and the state of disability in a large population with UC.
METHODS: We recruited consecutive patients with UC attending the inflammatory bowel disease (IBD) unit of the Azienda Ospedaliera of Padua between July and December 2017. We collected patients' characteristics and clinical information, and all participants completed the IBD questionnaire (IBDQ) for quality of life assessment and the IBD disability index (IBD-DI) questionnaire. Using univariate logistic regression models we assessed whether the patients' characteristics and IBD-related variables were associated with an IBD-DI score ≤3.5. Statistically significant variables in the univariate analyses were then included in a multivariate regression model. Correlations between IBD-DI and all the above mentioned characteristics were investigated using the Spearman's rank correlation coefficient.
RESULTS: We included 201 patients. A positive correlation was observed between IBD-DI and IBDQ (r = 0.82, P < 0.001). Multivariate regression modelling identified the following as independent factors related to disability: active disease (partial Mayo score ≥2) (odds ratio [OR] 6.54, 95% CI 3.21-13.22), the presence of extraintestinal manifestations (EIM) (OR 2.48, 95%, CI 1.11-5.54) and occasional alcohol consumption (OR 0.39, 95% CI 0.20-0.76).
CONCLUSIONS: Impaired disability is mainly correlated with disease activity, the presence of EIM and no alcohol consumption. Moreover, there is a strong correlation with patients' quality of life. Therefore, in clinical practice, greater awareness of IBD-related disability is needed to better manage patients' outcomes.
© 2019 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  disability; disease activity; fecal calprotectin; quality of life; ulcerative colitis

Mesh:

Year:  2020        PMID: 31859432     DOI: 10.1111/1751-2980.12837

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  4 in total

1.  A Survey on Nutritional Knowledge in Coeliac Disease Compared to Inflammatory Bowel Diseases Patients and Healthy Subjects.

Authors:  Ilaria Marsilio; Edoardo Vincenzo Savarino; Brigida Barberio; Greta Lorenzon; Daria Maniero; Linda Cingolani; Anna D'Odorico; Renata D'Incà; Fabiana Zingone
Journal:  Nutrients       Date:  2020-04-16       Impact factor: 5.717

2.  Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study.

Authors:  Davide Massimi; Brigida Barberio; Lorenzo Bertani; Francesco Costa; Antonio Ferronato; Sonia Facchin; Romilda Cardin; Linda Cingolani; Cesare Casadei; Renata D'Incà; Fabiana Zingone; Edoardo Vincenzo Savarino
Journal:  Therap Adv Gastroenterol       Date:  2021-06-27       Impact factor: 4.409

3.  Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation.

Authors:  Brigida Barberio; Edoardo Vincenzo Savarino; Timothy Card; Cristina Canova; Francesco Baldisser; Alessandro Gubbiotti; Davide Massimi; Matteo Ghisa; Fabiana Zingone
Journal:  Intest Res       Date:  2021-08-04

4.  Quality of Life in Newly Diagnosed Moderate-to-Severe Ulcerative Colitis: Changes in the MOSAIK Cohort Over 1 Year.

Authors:  Ik Hyun Jo; Kang-Moon Lee; Dae Bum Kim; Ji Won Kim; Jun Lee; Yoon Tae Jeen; Tae-Oh Kim; Joo Sung Kim; Jae Jun Park; Sung Noh Hong; Dong Il Park; Hyun-Soo Kim; Yoo Jin Lee; Youngdoe Kim
Journal:  Gut Liver       Date:  2022-05-15       Impact factor: 4.519

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.